In an interview with ET Now, Shashank Sinha, Strides Shasun, says their US portfolio is going to ramp up significantly and would probably double or nearly double in the next 12 to 15 months. Let us start first with the recent approval of g-Sustiva.
For More Details Visit-
via We have niche strategy in US, leadership strategy in Australia: Shashank Sinha, Strides Shasun
No comments:
Post a Comment